HomeCompareDKDRF vs CL

DKDRF vs CL: Dividend Comparison 2026

DKDRF yields 4.40% · CL yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DKDRF wins by $3006.16M in total portfolio value
10 years
DKDRF
DKDRF
● Live price
4.40%
Share price
$5.46
Annual div
$0.24
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3006.19M
Annual income
$2,880,304,973.66
Full DKDRF calculator →
CL
CL
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CL calculator →

Portfolio growth — DKDRF vs CL

📍 DKDRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDKDRFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DKDRF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DKDRF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DKDRF
Annual income on $10K today (after 15% tax)
$373.63/yr
After 10yr DRIP, annual income (after tax)
$2,448,259,227.61/yr
CL
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, DKDRF beats the other by $2,448,258,463.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DKDRF + CL for your $10,000?

DKDRF: 50%CL: 50%
100% CL50/50100% DKDRF
Portfolio after 10yr
$1503.11M
Annual income
$1,440,152,936.43/yr
Blended yield
95.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

DKDRF
No analyst data
Altman Z
3.4
Piotroski
6/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+84.9% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DKDRF buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDKDRFCL
Forward yield4.40%4.00%
Annual dividend / share$0.24$2.00
Payout ratio50%50%
1-year div growth0%5%
5-year div CAGR100%5%
Portfolio after 10y$3006.19M$28.0K
Annual income after 10y$2,880,304,973.66$899.19
Total dividends collected$2997.26M$6.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: DKDRF vs CL ($10,000, DRIP)

YearDKDRF PortfolioDKDRF Income/yrCL PortfolioCL Income/yrGap
1← crossover$11,579$879.12$11,120$420.00+$459.00DKDRF
2$14,292$1,902.70$12,357$458.31+$1.9KDKDRF
3$19,683$4,389.80$13,721$499.76+$6.0KDKDRF
4$32,360$11,299.79$15,227$544.58+$17.1KDKDRF
5$69,351$34,725.19$16,885$593.02+$52.5KDKDRF
6$213,306$139,100.90$18,713$645.34+$194.6KDKDRF
7$1,027,941$799,703.65$20,724$701.81+$1.01MDKDRF
8$8,303,344$7,203,446.91$22,938$762.73+$8.28MDKDRF
9$117,645,120$108,760,542.24$25,372$828.41+$117.62MDKDRF
10$3,006,185,252$2,880,304,973.66$28,047$899.19+$3006.16MDKDRF

DKDRF vs CL: Complete Analysis 2026

DKDRFStock

NewMed Energy - Limited Partnership engages in the exploration, development, production, and sale of petroleum, natural gas, and condensate in Israel and Cyprus. The company holds interests in the Leviathan project, which covers an area of 500 km2 located to the west of the shores of Haifa; the Block 12 that covers an area of approximately 386 km2 located in Cyprus; and the Yam Tethys project, which covers an area of 500 km2 located to the west of the shores of Ashkelon. It also holds interests in the New Ofek license that covers an area of approximately 344 km2 located in Israel; the New Yahel license, covering an area of 397.5 km2 located in Israel; and the Tanin and Karish leases covering an area of approximately 500km2 located to the west of the shores of Nahariya. The company serves independent power producers and various industrial enterprises. NewMed Energy Management Ltd. serves as the general partner of the company. The company was formerly known as Delek Drilling - Limited Partnership and changed its name to NewMed Energy - Limited Partnership in February 2022. NewMed Energy - Limited Partnership was incorporated in 1993 and is based in Herzliya, Israel. NewMed Energy - Limited Partnership is a subsidiary of Delek Energy Systems Ltd.

Full DKDRF Calculator →

CLConsumer Staples

CL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CL shares.

Full CL Calculator →
📬

Get this DKDRF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DKDRF vs SCHDDKDRF vs JEPIDKDRF vs ODKDRF vs KODKDRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.